| __timestamp | BioMarin Pharmaceutical Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 22223073 |
| Thursday, January 1, 2015 | 634806000 | 6966842 |
| Friday, January 1, 2016 | 661905000 | 9000499 |
| Sunday, January 1, 2017 | 610753000 | 13741186 |
| Monday, January 1, 2018 | 696328000 | 19040000 |
| Tuesday, January 1, 2019 | 715007000 | 23559000 |
| Wednesday, January 1, 2020 | 628116000 | 31931000 |
| Friday, January 1, 2021 | 628793000 | 44981000 |
| Saturday, January 1, 2022 | 649606000 | 54234000 |
| Sunday, January 1, 2023 | 746773000 | 63806000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments.
BioMarin has consistently increased its R&D expenses, with a notable 62% rise from 2014 to 2023. This growth underscores BioMarin's dedication to advancing its pipeline of therapies, particularly in rare genetic diseases.
In contrast, Viking Therapeutics has shown a remarkable 187% increase in R&D spending over the same period. This surge reflects Viking's aggressive pursuit of novel treatments in metabolic and endocrine disorders.
As these companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotech breakthroughs.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Exelixis, Inc. and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Dynavax Technologies Corporation